Deferoxamine mesylate
- Product NDC
- 52609-4504
- 11-digit product format
- 526094504
- Labeler code
- 52609
- Product ID
- 52609-4504_cbc75c16-6c82-869c-84a8-deaa76ebdb1c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Deferoxamine mesylate
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- ApoPharma USA, Inc.
- Application
- ANDA207384
- Marketing category
- ANDA
- Marketing start
- 2018-03-23
- Marketing end
- 0000-00-00
- Substance
- DEFEROXAMINE MESYLATE
- Active strength
- 2 g/1
- Pharmacologic classes
- Iron Chelating Activity [MoA],Iron Chelator [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 52609-4504-6 | Deferoxamine mesylate | 4 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 4 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 52609-4504 | DEFEROXAMINE MESYLATE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [APOPHARMA USA, INC.] | 1 | Legacy NDC, 1 package rows | 20180327_72348776-4971-bc49-8b66-67a2422567d4.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 52609-4504-6 | 52609450406 | 4 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (52609-4504-6) | 2018-03-23 | 0000-00-00 | No | No | Current |